Safety and efficacy of sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of an Italian expanded-access program (EAP) with subpopulation analysis

被引：0
|
作者：
Stemberg, Cora N.
Porta, Camillo
Bracarda, Sergio
Carteni, Giacomo
Lo Re, Giovanni
Ruggeri, Enzo M.
Conte, Pierfranco
Monfardini, Silvio
Gasparini, Giampietro
Ciuffreda, Libero
Marini, Giovanni
Bonetti, Andrea
Heouaine, Abdhelhamid
Bernardini, Ilaria
Ravaioli, Alberto
Labianca, Roberto
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：418 / 418
页数：1
相关论文
共 50 条
  • [1] Sunitinib in metastatic renal cell carcinoma (mRCC): preliminary assessment of safety and efficacy in an expanded access trial with subpopulation analysis
    Gore, M.
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G.
    Oudard, S.
    Lee, S. H.
    Carteni, G.
    Eberhardt, W.
    EJC SUPPLEMENTS, 2007, 5 (04): : 299 - 299
  • [2] Safety and efficacy of sunitinib in an expanded-access trial of metastatic renal cell carcinoma (MRCC): Updated results and subpopulation analysis
    Oudard, S.
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G.
    Lee, S. H.
    Carteni, G.
    Eberhardt, W.
    Gore, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 246 - 246
  • [3] Sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of toxicity in an expanded access trial with subpopulation analysis
    Gore, M. E.
    Porta, C.
    Oudard, S.
    Bjarnason, G.
    Castellano, D.
    Szczylik, C.
    Mainwaring, P. N.
    Schoffski, P.
    Rini, B. I.
    Bukowski, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] EXPANDED-ACCESS PROGRAM (EAP) OF SUNITINIB IN 458 PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Sternberg, C. N.
    Porta, C.
    Bracarda, S.
    Carteni, G.
    Lo Re, G.
    Ruggeri, E. M.
    Conte, P.
    Monfardini, S.
    Gasparini, G.
    Ciuffreda, L.
    ANNALS OF ONCOLOGY, 2008, 19 : 194 - 194
  • [5] Sunitinib expanded-access trial in metastatic renal cell carcinoma (mRCC) - final Italian results
    Sternberg, C.
    Bracarda, S.
    Carteni, G.
    Lo Re, G.
    Ruggeri, E. M.
    Masini, C.
    Fly, K.
    Zhang, K.
    Hariharan, S.
    Capaccetti, B.
    Porta, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S644 - S644
  • [6] Updated Safety and Efficacy Results for Sunitinib From a Global, Expanded-Access Trial in Metastatic Renal Cell Carcinoma (mRCC)
    Gore, M.
    Porta, C.
    Bracarda, S.
    Crino, L.
    Hawkins, R.
    Bjarnason, G.
    Oudard, S.
    Lee, S. H.
    Kim, T. M.
    Szczylik, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S515 - S515
  • [7] Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
    Gore, Martin E.
    Szczylik, Cezary
    Porta, Camillo
    Bracarda, Sergio
    Bjarnason, Georg A.
    Oudard, Stephane
    Hariharan, Subramanian
    Lee, Se-Hoon
    Haanen, John
    Castellano, Daniel
    Vrdoljak, Eduard
    Schoffski, Patrick
    Mainwaring, Paul
    Nieto, Alejandra
    Yuan, Jinyu
    Bukowski, Ronald
    LANCET ONCOLOGY, 2009, 10 (08): : 757 - 763
  • [8] Subpopulation analysis from an ongoing expanded-access trial of Sunitinib in metastatic renal cell carcinoma
    Eberhardt, W.
    Weigang-Koehler, K.
    Gruenwald, V.
    Fiedler, W.
    Steiner, T.
    Stoeckle, M.
    Bergmann, L.
    Casper, J.
    Wirth, M. P.
    Gore, M. E.
    ONKOLOGIE, 2008, 31 : 179 - 179
  • [9] Safety and efficacy of cabozantinib for metastatic renal cell carcinoma (mRCC): real world data from an Italian Expanded Access Program (EAP)
    Michele, P.
    Ratta, R.
    Iacovelli, R.
    Mancini, M.
    Fornarini, G.
    Facchini, G.
    Carteni, G.
    Napolitano, M.
    Del Bene, G.
    Santini, D.
    Soraru, M. Mariella
    Vitale, M. G.
    Ricotta, R.
    Tucci, M.
    Fedeli, S. Luzi
    Boe, M. G.
    Mecozzi, A.
    Ortega, C.
    Stemberg, C. N.
    Procopio, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] Safety and efficacy of nivolumab for metastatic renal cell carcinoma (mRCC): Real world data from an Italian expanded access program (EAP).
    De Giorgi, Ugo
    Scagliarini, Sarah
    Basso, Umberto
    Galli, Luca
    Mosillo, Claudia
    Caserta, Claudia
    Rossetti, Sabrina
    Guida, Annalisa
    Bearz, Alessandra
    Buti, Sebastiano
    Lo Re, Giovanni
    Valcamonico, Francesca
    Hamzaj, Alketa
    Cognetti, Francesco
    Rastelli, Francesca
    Fornarini, Giuseppe
    Porta, Camillo
    Del Bene, Gabriella
    Turci, Daniele
    Procopio, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345